Ru(ii)/Os(ii)-based carbonic anhydrase inhibitors as photodynamic therapy photosensitizers for the treatment of hypoxic tumours

Author:

Wang Youchao1,Mesdom Pierre1,Purkait Kallol1,Saubaméa Bruno2,Burckel Pierre3,Arnoux Philippe4,Frochot Céline4ORCID,Cariou Kevin1ORCID,Rossel Thibaud5ORCID,Gasser Gilles1ORCID

Affiliation:

1. Chimie ParisTech, CNRS, Institute of Chemistry for Life and Health Sciences, Laboratory for Inorganic Chemical Biology, PSL University, 75005, Paris, France

2. Cellular and Molecular Imaging Facility, US25 Inserm, UAR3612 CNRS, Faculté de Pharmacie de Paris, Université Paris Cité, F-75006, Paris, France

3. Institut de Physique du Globe de Paris, Biogéochimie à; l’Anthropocène des Eléments et Contaminants Emergents, 75005, Paris, France

4. Université de Lorraine, CNRS, LRGP, F-54000, Nancy, France

5. Institute of Chemistry, University of Neuchâtel, Avenue de Bellevaux 51, 2000, Neuchâtel, Switzerland

Abstract

Novel sulfonamide-based monopodal and dipodal ruthenium and osmium polypyridyl complexes capable of targeting carbonic anhydrases are a major target in cancer therapy are described as new photosensitizers for photodynamic therapy.

Funder

H2020 European Research Council

Agence Nationale de la Recherche

China Scholarship Council

Publisher

Royal Society of Chemistry (RSC)

Subject

General Chemistry

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3